Podiatrists in Richfield, UT Accepting Medicare

4 Podiatrists found. Showing 1 - 4

Sevier Podiatry Clinic Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 81 East 900 North, Richfield, UT 84701 Phone: 435-896-6497

Apex Foot And Ankle Institute Podiatrist - Foot & Ankle Surgery Medicare: Medicare Enrolled Practice Location: 882 N Main St # 2, Richfield, UT 84701 Phone: 435-287-2444

Viliami Haangana Vakautakakala, DPM Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 880 N Main St, Richfield, UT 84701 Phone: 435-896-0668

Dr. Blake O. Zobell, DPM Podiatrist Medicare: May Accept Medicare Assignments Practice Location: 879 N Main St, Richfield, UT 84701 Phone: 435-896-6497    Fax: 435-896-9564

News Archive

Discovery of chromosomal abnormality that appears to increase susceptibility to autism

A multi-institutional study involving Massachusetts General Hospital (MGH) researchers has identified a chromosomal abnormality that appears to increase susceptibility to autism.

African leaders, international community must act on commitments made at London family planning summit

In this UNFPA opinion piece, Babatunde Osotimehin, U.N. under-secretary-general and UNFPA executive director, and Sharon Camp, president and CEO of the Guttmacher Institute, reflect on last month's London Summit on Family Planning, where "leaders from 18 African countries made unprecedented commitments - financially and politically - to strengthen their family planning programs,"

Alterations in intestinal microbiota may lie behind IBS aetiology

Irritable bowel syndrome (IBS) is a common gastrointestinal functional disorder that can greatly affect the patient's well being. Multiple interacting mechanisms, including alterations in the intestinal microbiota, are suspected to lie behind IBS aetiology.

Standard smartphone technology can be adapted to image skin lesions

An article published in the Journal of Biomedical Optics (JBO), "Point-of-care, multispectral, smartphone-based dermascopes for dermal lesion screening and erythema monitoring," shows that standard smartphone technology can be adapted to image skin lesions, providing a low-cost, accessible medical diagnostic tool for skin cancer.

FDA permits marketing of ClonoSEQ assay to detect minimal residual disease in blood cancer patients

Today the U.S. Food and Drug Administration permitted marketing of ClonoSEQ assay, a next generation sequencing-based test for minimal residual disease in patients with acute lymphoblastic leukemiaor multiple myeloma. MRD is a measure of the amount of cancer cells remaining in a person's bone marrow.

Read more Medical News

› Verified 1 days ago